Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid in Combination With Topical Hydroquinone for Refractory Melasma

NCT06522984 is registered in ClinicalTrials.gov with Egymedicalpedia as lead sponsor.

NCT NCT06522984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06522984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid in Combination With Topical Hydroquinone for Refractory Melasma
Lead sponsor
Egymedicalpedia
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2024
Completion date
June 10, 2025
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory melasma